Mankind Pharma Ltd. (IN:MANKIND)
:MANKIND
Want to see IN:MANKIND full AI Analyst Report?
MANKIND Analyst Ratings
Moderate Buy
3 Buy
0 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MANKIND Stock 12 Month Forecast
Average Price Target
₹2,636.75
▲(19.71% Upside)
| Highest Price Target₹3,000 | Average Price Target₹2,637 | Lowest Price Target₹2,057 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
J.P. Morgan
₹2,850
Buy
29.40%
Upside
Reiterated
05/22/26
Jefferies
₹3,000
Buy
36.21%
Upside
Reiterated
05/20/26
Motilal Oswal
₹2,640
Buy
19.86%
Upside
Reiterated
04/29/26
Kotak Mahindra
₹2,800
Buy
27.13%
Upside
Reiterated
09/29/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
J.P. Morgan
₹2,850
Buy
29.40%
Upside
Reiterated
05/22/26
Jefferies
₹3,000
Buy
36.21%
Upside
Reiterated
05/20/26
Motilal Oswal
₹2,640
Buy
19.86%
Upside
Reiterated
04/29/26
Kotak Mahindra
₹2,800
Buy
27.13%
Upside
Reiterated
09/29/25
Best Analysts Covering Mankind Pharma Ltd.
3 Months
Success Rate
3/6 ratings generated profit
Average Return
-1.60%
Copying Bansi Desai's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -1.60% per trade.
1 Year
Success Rate
2/6 ratings generated profit
Average Return
-2.73%
Copying Bansi Desai's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -2.73% per trade.
2 Years
Success Rate
2/6 ratings generated profit
Average Return
-2.07%
Copying Bansi Desai's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -2.07% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MANKIND Analyst Recommendation Trends
Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
0
0
Buy
1
1
2
3
3
Hold
0
0
0
0
0
Sell
0
0
0
0
1
Strong Sell
0
0
0
0
0
total
1
1
2
3
4
Each month's total comprises the sum of three months' worth of ratings.
MANKIND Financial Forecast
MANKIND Stock Forecast FAQ
What is IN:MANKIND’s average 12-month price target, according to analysts?
Based on analyst ratings, Mankind Pharma Ltd.’s 12-month average price target is 2,636.75.
What is IN:MANKIND’s upside potential, based on the analysts’ average price target?
Mankind Pharma Ltd. has 19.71% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Mankind Pharma Ltd. a Buy, Sell or Hold?
Mankind Pharma Ltd. has a consensus rating of Moderate Buy, which is based on 3 buy ratings, 0 hold ratings and 1 sell ratings.
What is Mankind Pharma Ltd.’s share price target?
The average share price target for Mankind Pharma Ltd. is 2,636.75. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is ₹3,000.00 ,and the lowest forecast is ₹2,057.00. The average share price target represents 19.71% Increase from the current price of ₹2,202.55.
The highest analyst share price target is ₹3,000.00 ,and the lowest forecast is ₹2,057.00. The average share price target represents 19.71% Increase from the current price of ₹2,202.55.
What do analysts say about Mankind Pharma Ltd.?
Mankind Pharma Ltd.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of Mankind Pharma Ltd.?
To buy shares of IN:MANKIND, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.